The opioid epidemic led to an increase in the number of neonatal opioid withdrawal
syndrome (NOWS) cases in infants born to opioid-dependent mothers. Hallmark features of …

Introduction: Infants exposed to opioids in utero are at high risk of exhibiting Neonatal Opioid
Withdrawal Syndrome (NOWS), a combination of somatic withdrawal symptoms including …

As the opioid epidemic continues to grow, opioid use among pregnant women is increasing
significantly. This has led to a steady rise in the number of infants born with neonatal opioid …

The devastating impact of opioid abuse and dependence on the individual, family, and
society are well known but extremely difficult to combat. During pregnancy, opioid drugs and …

Opioid use by women during pregnancy has risen dramatically since 2004, accompanied by
a striking increase in the prevalence of neonatal opioid withdrawal syndrome (NOWS) and …

Rationale In utero opioid exposure is associated with lower weight and a neonatal opioid
withdrawal syndrome (NOWS) at birth, along with longer-term adverse neurodevelopmental …

Nationwide, opioid misuse among pregnant women has risen four-fold from 1999 to 2014,
with commensurate increase in neonates hospitalized for neonatal abstinence syndrome …

Neonatal opioid withdrawal syndrome (NOWS) is a growing public health concern. The
complexity of in utero opioid exposure in clinical studies makes it difficult to investigate …

Opioid use among pregnant women is a growing public health concern in the United States.
Infants exposed to opioids in utero are at risk of exhibiting neonatal opioid withdrawal …

Opioid drugs are increasingly being prescribed to pregnant women. Such compounds can
also bind and activate opioid receptors in the fetal brain, which could lead to long-term brain …